Biotech News

ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance, Expecting Results at the High End of Range

ICU Medical (ICUI)ICU MedicalEarnings

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2026.

Related news

ICU Medical

Infusion and Critical Care ICU Medical develops, manufactures and sells medical products used to deliver therapies and manage critically ill patients. Its portfolio serves hospitals, alternate-care sites and home-care settings worldwide. Infusion Systems The company supplies infusion systems that control and monitor the delivery of...

Recent company news

Stock data

Close
167.65 USD
Market cap
3.26B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States